News | Radiation Therapy | February 26, 2016

New Venture Medical Releases Anti-radiation Treatment for Cancer Patients

Product will help heal radiation burns and protect healthy cells from radiation damage

New Venture Medical, anti-radiation exposure product, cancer treatment

February 26, 2016 — New Venture Medical announced the release of an anti-radiation product from their research and development group that the companys said is a breakthrough in the treatment of cancer using radiation and the treating of environmental radiation exposure. It will assist in the healing of radiation burns, even when open sores are present. It will also protect only the healthy cells from radiation damage. It selectively helps and protects the healthy cells and not tumors.

The initial product is for radiation exposure and this will be available as an injectable liquid or as a sublingual pill or a topical cream. The product is designed to work at the subatomic level in the individual cell's mitochondria. It has significant impact not only in the treatment of cancer, but any exposure to radiation. It has the ability to penetrate through the brain/blood barrier enabling it to be effective against cell phone radiation emissions.

For more information: www.newventuremedical.com

Related Content

Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Veterans Integrated Service Network 19 Implements System-Wide Radiation Dose Monitoring
News | Radiation Dose Management | December 04, 2018
Agfa HealthCare announced it has collaborated in delivering a system-wide DoseMonitor automated software implementation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...